Smallpox


  • Expert Ponders Whether Remaining Stockpiles of Smallpox Virus Should be Destroyed
    Raymond S. Weinstein, a clinical associate professor of medicine at Georgetown University School of Medicine in Washington, D.C. and a research professor at George Mason University in Manassas, Va., ponders the question of whether the remaining stockpile of variola -- which ...More
    April 6, 2011
    Posted in News
  • BARDA Supports Next Steps for a New Antiviral Drug for Smallpox
    A $24.8 million federal contract will support development a new antiviral drug to treat smallpox. The Biomedical Advanced Research and Development Authority (BARDA), within the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness ...More
    February 17, 2011
    Posted in News
  • Human Monkeypox Rising Sharply in Africa, Popping Up in U.S.
    In the winter of 1979, the world celebrated the end of smallpox, a highly contagious and often fatal viral infection estimated to have caused between 300 and 500 million deaths during the 20th century. The virus was eradicated through an aggressive worldwide vaccination ...More
    September 1, 2010
    Posted in News
  • Repurposing the Smallpox Vaccine to Battle HIV
    Researchers from The Wistar Institute recently reported that a human adenovirus called AdHu26, once thought uncommon, is not so rare after all. This could be bad news for scientists eager to use engineered AdHu26 human adenoviruses as vaccines against HIV and other ...More
    August 23, 2010
    Posted in News
  • First Smallpox Vaccine for Special Populations Delivered Under Project BioShield
    Delivery to the Strategic National Stockpile of the first 1 million doses of the nation’s first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract. ...More
    July 28, 2010
    Posted in News
  • Conference on Vaccine Research to Highlight 40-Year Progress
    Scientists at the 13th annual Conference on Vaccine Research (ACVR), sponsored by the National Foundation for Infectious Diseases (NFID), will reflect on the remarkable growth of vaccine biotechnology in the last several decades and focus on the growing number of ...More
    April 26, 2010
    Posted in News
  • Researcher Says Trying to Eradicate a Disease is a Waste of Money
    Eradicating smallpox was one of the greatest human accomplishments of the 20th century, but new research shows initiatives of this kind are not as good a use of health dollars as people might think. McGill University biologist Dr. Jonathan Davies explains that reducing the ...More
    April 15, 2010
    Posted in News
  • Outfoxing Pox: Developing a New Class of Vaccine Candidates
    By Richard HarthIn the annals of medicine, Edward Jenner's 1796 vaccination of a young boy against smallpox, using fluid from cowpox blisters, remains a landmark case. In a new study, Kathryn Sykes, a researcher at Arizona State University's Biodesign Institute and her ...More
    October 15, 2009
    Posted in News
  • Promising Antimicrobial Attacks Virus, Stimulates Immune System
    A promising antimicrobial agent already known to kill bacteria can also kill viruses and stimulate the innate immune system, according to researchers at National Jewish Health. In a paper appearing online June 4 in the Journal of Investigative Dermatology, Michael Howell, ...More
    June 4, 2009
    Posted in News
  • Unlocking the Mystery of Potentially Fatal Reaction to Smallpox Vaccine
    Researchers from the La Jolla Institute for Allergy & Immunology have pinpointed the cellular defect that increases the likelihood, among eczema sufferers, of developing eczema vaccinatum, a severe and potentially fatal reaction to the smallpox vaccine. The research, ...More
    May 26, 2009
    Posted in News
« Previous123456789101112Next »